TI-26-018: Emergency Department Alternatives to Opioids Program
Closed
This grant is closed. A newer notice from the same program is forecast: Emergency Department Alternatives to Opioids Program (TI-27-005). Status: Forecast, no dates yet. It is in our archive of Substance Abuse and Mental Health Services Adminis notices from 2026.
Substance Abuse and Mental Health Services Adminis offered grants of up to $500,000 to the applicants described in the notice. It expected to make about 12 awards worth $6.0 million in total. Applications closed on July 27, 2026.
From the official notice on Grants.gov, last changed July 1, 2026. Checked November 7, 2026.
- Award ceiling$500,000
- Total funding$6.0 million
- Expected awards12
- Cost sharingNot required
- Funding typeGrant
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| TI-27-005 | September 3, 2026 | Forecast, no dates yet | Forecast |
Key dates
| Posted | July 1, 2026 |
|---|---|
| Deadline | July 27, 2026 |
| Archived by Grants.gov | August 26, 2026 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligibility is statutorily limited to hospitals and emergency departments, including free standing emergency departments and rural emergency hospitals.
Is this a realistic fit?
- Past Opioid STR awards averaged $6.2 million; this notice allows up to $500,000 per award.
- Most of the program's money (92% over five years) went to state and local governments.
- No cost sharing or match is required.
What the grant funds
The purpose of the program is to establish and implement practices which will help your organization develop alternatives to pharmacological opioid interventions, reduce the potential harmful consequences of opioid use for pain care in hospitals and emergency departments, thereby promoting safer pain treatment and reducing the risk of future opioid misuse and possible opioid overdose.
Who has won Opioid STR grants before
From fiscal 2021 to 2025, Opioid STR (93.788) awarded $2.1 billion across 336 grant awards, an average of $6.2 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Ohio Department Mental Health | Ohio | 2 | $154 million |
| Pennsylvania Department of Drug and Alcohol Programs | Pennsylvania | 2 | $138 million |
| California Department of Health Care Services | California | 1 | $108 million |
| Maryland Department of Health | Maryland | 2 | $105 million |
| Delaware Department of Health and Social Services | Delaware | 2 | $104 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, TI-27-005, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is TI-26-018 still open?
No. It closed on July 27, 2026. A newer notice is forecast: TI-27-005, forecast, no dates yet.
Who can apply for Emergency Department Alternatives to Opioids Program?
Substance Abuse and Mental Health Services Adminis accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Emergency Department Alternatives to Opioids Program?
Closed July 27, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $500,000 each. About $6.0 million in total across about 12 awards.
Who has won Opioid STR grants before?
The largest recipients over five fiscal years were Ohio Department Mental Health, Pennsylvania Department of Drug and Alcohol Programs, California Department of Health Care Services. The program made 336 awards worth $2.1 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)